Supplier Type
- Manufacturer
- Reagent
- Trader
- custom synthesis
- contract manufacturer
Supplier Region
- Maharashtra(36)
- Uttar Pradesh(7)
- Tamil Nadu(3)
- New Delhi(5)
- Hyderabad(28)
- Mumbai(55)
- Andhra Pradesh(5)
- Gujarat(33)
- Delhi(25)
- Karnataka(8)
- Vadodara(30)
- Telangana(3)
- Bangalore(3)
- Ahmedabad(14)
- Pune(8)
- Madhya Pradesh(6)
- Haryana(2)
- Rajasthan(2)
- Kolkata(2)
- Punjab(1)
- Kerala(1)
- Beijing(1)
- Nagpur(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Pure
- Potassium content 15.5 - 17.5
- NLT 98%
- NLT 95%
- NLT 90%
- more than 95%
- more than 90%
- Min.96%
- Min. 0.4%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Magnesium content 8.49% to 8.84%
- lemon-lime grade (purity, 70%), a clear water-white ...
- Greater than 99%
- Dipropargyl r- amino indane
- Dapagliflozin Intermediate, Dapagliflozin Impurity
- Chemically Pure
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99
- 99.98%
- 99.95%
- 99.91%
- 99.9%
- 99.86%
- 99.85%
- 99.83%
- 99.8%
- 99.73%
- 99.50%
- 99.5%
- 99.47%
- 99.46%
- 99.42%
- 99.29%
- 99.23%
- 99.2%
- 99.05%
- 99.00%
- 99.0% e.e. Min
- 99.0%
- 99% minimum
- 99%
- >99%
- 99 %
- 99
- 98+
- 98.85%
- 98.60%
- 98.5 to 101.5%
- 98.12%
- 98.00%
- 98%+
- 98%
- >98%
- 98 %
- 97-99%
- 97.57%
- 97%
- >97%
- 97 %
- 96.80%
- 96.39%
- 96%
- 95.00%
- 95% min
- >95%
- 95%
- 94.84%
- 94.25%
- 94.00%
- 94%
- 93 %- 101%
- 92.55%
- >92%
- 90%
- >90%
- 90 % Above
- 90
- 75 %
- 67%
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 100%
- 10%
- 0.15 %
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 100mg
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 25mg
- 50mg
- 250mg
- 500mg
- 1g
- 1000mg
- 1gm
- 5g
- 10g
- 10Gram
- 25g
- 50g
- 100gm
- 100g
- 500g
- 500gm
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
-
Lincomycin
154-21-2
-
Clindamycin
18323-44-9
-
4-Fluorobenzeneboronic acid
1765-93-1
-
Cyclopentanecarboxylic acid
3400-45-1
-
Sodium Phosphate, Dibasic
7558-79-4
-
Sitagliptin phosphate monohydrate
654671-77-9
-
Clindamycin hydrochloride
21462-39-5
-
4-Aminopyrazolo[3,4-d]pyrimidine
2380-63-4
-
Sodium Phosphate Monobasic Monohydrate
10049-21-5
-
((3AS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)(morpholino)methanone
1103738-19-7
Clindamycin Phosphate EP Impurity A 154-21-2
4-Fluorophenylboronic acid 1765-93-1
Sodium phosphate dibasic 7558-79-4
Sitagliptin phosphate hydrate 654671-77-9
Clindamycin hydrochloride 21462-39-5
4-Amino-1H-pyrazolo[3,4-d]pyrimidine 2380-63-4
Sodium dihydrogen phosphate monohydrate 10049-21-5
(5S)-D-xylo-Pentodialdo-5,2-furanose, 4,5-O-(1-Methylethylidene)-1-C-4-Morpholinyl 1103738-19-7
Betamethasone 21-phosphate sodium 151-73-5
D-Norpseudoephedrine 492-39-7